Trials / Completed
CompletedNCT02066701
Gene Methylation in the Diagnosis of Barrett's Esophagus: Identification of Candidate Diagnostic Markers
Utility of Aberrant Gene Methylation in the Diagnosis of Barrett's Esophagus: Identification of Candidate Diagnostic Markers
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 250 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study is to identify potential markers from esophageal biopsies and brush cytology for feasibility of use in stool specimens for detection of Barretts Esophagus.
Conditions
Timeline
- Start date
- 2012-05-01
- Primary completion
- 2016-12-01
- Completion
- 2016-12-01
- First posted
- 2014-02-19
- Last updated
- 2017-08-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02066701. Inclusion in this directory is not an endorsement.